Osteoporosis can be medicated by lifestyle changes and sometimes medication. Both may be the choice of people with osteoporosis But recent research presents that Fosamax, a drug that cures osteoporosis, may be substituted with dried fruits in order to beat osteoporosis. Additional researches also suggest that fracture follow-up can work as osteoporosis prevention.
Due to recent issues of Fosamax drug, patients may be encouraged to eat dried plums instead. However, always inquire to your healthcare expert about your decisions on your health conditions.
Dried Plums Instead of Fosamax?
Among the vegan recipes countering osteoporosis, dried plums are the most effective in elevating bone mineral density and promoting overall bone health. This study is conducted by researchers from Florida State University. Its publication is in the British Journal of Nutrition.
Researchers refer to the regular consumption of dried plums as a “simple, proactive solution to help prevent fractures and osteoporosis.
The study further revealed that dried plums have the ability to suppress the accelerated bone resorption process in older individuals, which ends up exceeding the body's capacity to produce new bone tissue.
The researcher also claimed that postmenopausal women who regularly eat dried plums have a lower risk of having osteoporosis compared to other women of the same age.
Women are More Susceptible to Osteoporosis
Postmenopausal women encounter osteoporosis more often because it is directly linked to the cessation of ovarian function. However, researcher Bahram Arjmandi said that men will also begin to encounter bone tissue loss as their testosterone production dramatically decreases by the age of 65.
"In the first five to seven postmenopausal years, women are at risk of losing bone at a rate of 3 to 5 percent per year," Arjmandi explained.
In the United States alone, there are around 8 million women and 2 million men suffer from osteoporosis. This is based on the current figures.
The Issues about Fosamax?
After the publication of a number of studies that link Fosamax to abnormal bone cracks and the release of a U.S. Food and Drug Administration (FDA) warning in October, Fosamax lawsuits became one of the biggest issues being faced by Merck.
References:
sciencedaily.com/releases/2011/08/110818093048.htm
No comments:
Post a Comment